Compare Stocks: DCTH, INSP, AXGN, and ESTA

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AXGN AxoGen	$36.68 +0.5%	$43.68	$17.14 ▼ $52.91	$1.97B	1.17	1.15 million shs	961,577 shs
DCTH Delcath Systems	$14.75 +0.3%	$15.99	$8.12 ▼ $17.42	$511.83M	0.6	459,039 shs	400,929 shs
ESTA Establishment Labs	$63.52 +2.0%	$68.43	$47.00 ▼ $97.59	$1.89B	1.06	513,416 shs	762,400 shs
INSP Inspire Medical Systems	$72.82 +2.5%	$66.97	$38.91 ▼ $147.03	$2.11B	0.73	1.06 million shs	659,691 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AXGN AxoGen	+0.86%	+3.81%	-20.57%	-8.18%	+108.58%
DCTH Delcath Systems	-0.41%	-0.14%	-8.75%	+18.26%	+29.06%
ESTA Establishment Labs	+1.98%	+7.60%	-8.06%	-31.64%	+26.25%
INSP Inspire Medical Systems	-0.63%	+4.35%	-5.85%	+40.02%	-14.40%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AXGN AxoGen	$36.68 +0.5%	$43.68	$17.14 ▼ $52.91	$1.97B	1.17	1.15 million shs	961,577 shs
DCTH Delcath Systems	$14.75 +0.3%	$15.99	$8.12 ▼ $17.42	$511.83M	0.6	459,039 shs	400,929 shs
ESTA Establishment Labs	$63.52 +2.0%	$68.43	$47.00 ▼ $97.59	$1.89B	1.06	513,416 shs	762,400 shs
INSP Inspire Medical Systems	$72.82 +2.5%	$66.97	$38.91 ▼ $147.03	$2.11B	0.73	1.06 million shs	659,691 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AXGN AxoGen	+0.86%	+3.81%	-20.57%	-8.18%	+108.58%
DCTH Delcath Systems	-0.41%	-0.14%	-8.75%	+18.26%	+29.06%
ESTA Establishment Labs	+1.98%	+7.60%	-8.06%	-31.64%	+26.25%
INSP Inspire Medical Systems	-0.63%	+4.35%	-5.85%	+40.02%	-14.40%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AXGN AxoGen	2.80	Moderate Buy	$51.73	41.02% Upside
DCTH Delcath Systems	2.60	Moderate Buy	$24.50	66.10% Upside
ESTA Establishment Labs	2.80	Moderate Buy	$98.56	55.16% Upside
INSP Inspire Medical Systems	2.05	Hold	$68.82	-5.48% Downside

Current Analyst Ratings Breakdown

Latest DCTH, INSP, AXGN, and ESTA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/15/2026	ESTA Establishment Labs	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$117.00
10/14/2026	ESTA Establishment Labs	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target	Buy	$85.00
10/14/2026	INSP Inspire Medical Systems	Truist Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Hold	$62.00 ➝ $78.00
10/13/2026	DCTH Delcath Systems	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C-) ➝ Hold (C)
10/13/2026	INSP Inspire Medical Systems	Mizuho Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$75.00
10/12/2026	AXGN AxoGen	Bank of America Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Buy	$52.00
10/6/2026	INSP Inspire Medical Systems	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Underweight	$65.00
10/6/2026	AXGN AxoGen	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Overweight	$55.00
10/6/2026	AXGN AxoGen	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Strong-Buy
10/6/2026	DCTH Delcath Systems	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Strong-Buy ➝ Hold
10/6/2026	INSP Inspire Medical Systems	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Strong Sell

(Data available from 10/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AXGN AxoGen	$225.21M	8.76	N/A	N/A	$2.79 per share	13.15
DCTH Delcath Systems	$85.23M	6.01	$0.05 per share	282.36	$3.15 per share	4.68
ESTA Establishment Labs	$211.08M	8.97	N/A	N/A	$0.81 per share	78.42
INSP Inspire Medical Systems	$911.98M	2.31	$2.92 per share	24.91	$26.88 per share	2.71

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AXGN AxoGen	-$15.70M	-$0.68	N/A	407.56	N/A	-13.36%	-8.90%	-6.47%	10/28/2026 (Estimated)
DCTH Delcath Systems	$2.70M	$0.01	1,476.48	122.92	N/A	0.56%	0.46%	0.42%	11/3/2026 (Estimated)
ESTA Establishment Labs	-$51.06M	-$1.31	N/A	N/A	N/A	-15.82%	-196.69%	-10.73%	10/29/2026 (Confirmed)
INSP Inspire Medical Systems	$145.42M	$4.62	15.76	47.28	5.39	15.03%	8.64%	7.45%	11/2/2026 (Estimated)

Latest DCTH, INSP, AXGN, and ESTA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/3/2026	Q3 2026	DCTH Delcath Systems	-$0.10	N/A	N/A	N/A	$26.00 million	N/A
11/2/2026	Q3 2026	INSP Inspire Medical Systems	$0.0870	N/A	N/A	N/A	$204.31 million	N/A
10/29/2026	Q3 2026	ESTA Establishment Labs	-$0.2568	N/A	N/A	N/A	$66.81 million	N/A
10/28/2026	Q3 2026	AXGN AxoGen	$0.1340	N/A	N/A	N/A	$73.18 million	N/A
8/6/2026	Q2 2026	DCTH Delcath Systems	-$0.0891	$0.07	+$0.1591	$0.07	$26.25 million	$29.13 million
8/6/2026	Q2 2026	ESTA Establishment Labs	-$0.3368	-$0.39	-$0.0532	-$0.39	$65.79 million	$67.54 million
8/3/2026	Q2 2026	INSP Inspire Medical Systems	-$0.2359	$0.14	+$0.3759	$0.01	$194.72 million	$200.58 million
7/29/2026	Q2 2026	AXGN AxoGen	$0.1214	$0.12	-$0.0014	-$0.03	$67.10 million	$69.73 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AXGN AxoGen	N/A	N/A	N/A	N/A	N/A
DCTH Delcath Systems	N/A	N/A	N/A	N/A	N/A
ESTA Establishment Labs	N/A	N/A	N/A	N/A	N/A
INSP Inspire Medical Systems	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AXGN AxoGen	0.07	6.60	5.04
DCTH Delcath Systems	N/A	9.83	8.95
ESTA Establishment Labs	12.11	3.84	2.52
INSP Inspire Medical Systems	N/A	8.55	6.16

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AXGN AxoGen	80.29%
DCTH Delcath Systems	61.12%
ESTA Establishment Labs	72.91%
INSP Inspire Medical Systems	94.91%

Insider Ownership

Company	Insider Ownership
AXGN AxoGen	2.44%
DCTH Delcath Systems	19.36%
ESTA Establishment Labs	9.99%
INSP Inspire Medical Systems	2.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AXGN AxoGen	622	53.76 million	52.45 million	Optionable
DCTH Delcath Systems	156	34.70 million	27.98 million	Optionable
ESTA Establishment Labs	1,004	29.80 million	26.83 million	Optionable
INSP Inspire Medical Systems	1,333	28.91 million	28.27 million	Optionable

DCTH, INSP, AXGN, and ESTA Headlines

Recent News About These Companies

Georgia Melenikiotou Receives 255 Inspire Medical Systems Shares as Director Compensation on October 14, 2026

October 18, 2026 | kalkinemedia.comK

Assenagon Asset Management S.A. Sells 221,080 Shares of Inspire Medical Systems, Inc. $INSP

October 18, 2026 | marketbeat.com

Inspire Medical Systems (NYSE:INSP) Stock Price Expected to Rise, Truist Financial Analyst Says

October 14, 2026 | marketbeat.com

Leerink Partners Remains a Hold on Inspire Medical Systems (INSP)

October 13, 2026 | theglobeandmail.com

Inspire Medical Systems (NYSE:INSP) Stock Price Up 4% - Here's What Happened

October 12, 2026 | marketbeat.com

Inspire Medical Systems Inc (INSP) Stock Up 3.3% and Still Undervalued -- GF Score: 64/100

October 9, 2026 | gurufocus.com

Inspire Medical Systems (NYSE:INSP) Stock Bumped Up to "Strong Sell" by Barclays

October 9, 2026 | marketbeat.com

Barclays initiates coverage of Inspire Medical Systems at underweight

October 8, 2026 | msn.com

Barclays Initiates Inspire Medical Systems at Underweight With $65 Price Target

October 7, 2026 | marketscreener.comM

How Investors Are Reacting To Inspire Medical Systems (INSP) Securing Category I CPT Codes For Inspire V

October 5, 2026 | finance.yahoo.com

Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026

October 5, 2026 | globenewswire.com

Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation

October 5, 2026 | zacks.com

Medical devices & supplies - specialty stocks Q2 earnings review: Inspire Medical Systems (NYSE:INSP) shines

October 5, 2026 | msn.com

Piper Sandler Remains a Hold on Inspire Medical Systems (INSP)

October 4, 2026 | theglobeandmail.com

RBC Raises Price Target on Inspire Medical Systems to $75 From $60, Keeps Sector Perform Rating

October 2, 2026 | marketscreener.comM

Inspire Secures AMA Approval For New Hypoglossal Nerve Stimulation Codes

October 2, 2026 | rttnews.com

Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel

October 1, 2026 | globenewswire.com

Inspire Medical Systems, Inc. (NYSE:INSP) Receives Consensus Rating of "Hold" from Analysts

October 1, 2026 | marketbeat.com

Inspire Medical Systems (INSP) Stock Could Be A Bargain On Cash Flow

September 30, 2026 | finance.yahoo.com

Inspire Medical Systems (NYSE:INSP) Stock Falls 6.2% - Time to Sell?

September 30, 2026 | marketbeat.com

Which Is a Better Investment, Butterfly Network, Inc. or Inspire Medical Systems, Inc. Stock?

September 28, 2026 | aaii.comA

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

DCTH, INSP, AXGN, and ESTA Company Descriptions

AxoGen NASDAQ:AXGN

$36.68 +0.20 (+0.55%)

Closing price 04:00 PM Eastern

Extended Trading

$36.68 0.00 (0.00%)

As of 04:41 PM Eastern

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

Delcath Systems NASDAQ:DCTH

$14.75 +0.05 (+0.34%)

Closing price 04:00 PM Eastern

Extended Trading

$14.74 -0.01 (-0.07%)

As of 04:25 PM Eastern

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

Establishment Labs NASDAQ:ESTA

$63.52 +1.24 (+1.99%)

Closing price 04:00 PM Eastern

Extended Trading

$63.47 -0.05 (-0.08%)

As of 04:25 PM Eastern

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Inspire Medical Systems NYSE:INSP

$72.82 +1.75 (+2.46%)

Closing price 03:59 PM Eastern

Extended Trading

$72.68 -0.14 (-0.19%)

As of 04:25 PM Eastern

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest DCTH, INSP, AXGN, and ESTA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest DCTH, INSP, AXGN, and ESTA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

DCTH, INSP, AXGN, and ESTA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

DCTH, INSP, AXGN, and ESTA Company Descriptions

AxoGen NASDAQ:AXGN

Delcath Systems NASDAQ:DCTH

Establishment Labs NASDAQ:ESTA

Inspire Medical Systems NYSE:INSP

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest DCTH, INSP, AXGN, and ESTA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest DCTH, INSP, AXGN, and ESTA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

DCTH, INSP, AXGN, and ESTA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

DCTH, INSP, AXGN, and ESTA Company Descriptions

AxoGen NASDAQ:AXGN

Delcath Systems NASDAQ:DCTH

Establishment Labs NASDAQ:ESTA

Inspire Medical Systems NYSE:INSP

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools